Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase III metastatic castration resistant prostate cancer trial
暂无分享，去创建一个
Y. Tai | I. Thompson | C. Tangen | N. Agarwal | R. Cote | C. Higano | M. Carducci | A. Goldkorn | P. Mack | D. Quinn | N. Vogelzang | M. Hussain | M. Garzotto | P. Lara | P. Twardowski | Tong Xu | J. Monk | P. Veldhuizen | B. Ely | Hongli Li | I. Thompson